Phase III Clinical Trial Flop Scuttles Vectura ‘s Desires for Broadening Flutiform into COPD
British-based pharmaceutical company, Vectura can set aside its hopes of getting a new COPD (Chronic Obstructive Pulmonary Disease) indication for
Read more
Clinical Research Society
International Society for Clinical Research and Translational Medicine